1. Home
  2. UTHR

as 10-30-2025 9:32am EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Founded: 1996 Country:
United States
United States
Employees: N/A City: SILVER SPRING
Market Cap: 20.7B IPO Year: 1999
Target Price: $471.50 AVG Volume (30 days): 658.6K
Analyst Decision: Buy Number of Analysts: 14
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 26.38 EPS Growth: 16.08
52 Week Low/High: $266.98 - $479.50 Next Earning Date: 10-29-2025
Revenue: $3,128,400,000 Revenue Growth: 13.50%
Revenue Growth (this year): 13.82% Revenue Growth (next year): 5.71%

Stock Insider Trading Activity of United Therapeutics Corporation (UTHR)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
BENKOWITZ MICHAEL UTHR PRESIDENT AND COO Oct 27 '25 Sell $417.50 22,500 $9,393,671.25 130
ROTHBLATT MARTINE A UTHR Chairperson & CEO Oct 24 '25 Sell $424.86 4,000 $1,696,259.41 1,193
ROTHBLATT MARTINE A UTHR Chairperson & CEO Oct 23 '25 Sell $422.79 4,000 $1,688,729.50 1,193
ROTHBLATT MARTINE A UTHR Chairperson & CEO Oct 22 '25 Sell $421.90 4,000 $1,688,607.13 1,193
ROTHBLATT MARTINE A UTHR Chairperson & CEO Oct 21 '25 Sell $428.53 4,000 $1,711,042.64 1,193
ROTHBLATT MARTINE A UTHR Chairperson & CEO Oct 20 '25 Sell $425.96 4,000 $1,698,349.58 1,193
BENKOWITZ MICHAEL UTHR PRESIDENT AND COO Oct 20 '25 Sell $427.41 22,500 $9,616,702.50 130
ROTHBLATT MARTINE A UTHR Chairperson & CEO Oct 17 '25 Sell $431.18 4,000 $1,722,686.97 1,193
ROTHBLATT MARTINE A UTHR Chairperson & CEO Oct 16 '25 Sell $431.53 4,000 $1,725,252.57 1,193
MAHON PAUL A UTHR EVP & GENERAL COUNSEL Oct 16 '25 Sell $432.08 11,000 $4,746,494.14 43,826

Share on Social Networks: